Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Tramadol Hydrochloride Extended -release Tablets USP, 100 mg, 200 mg and 300 mg.
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Tramadol Hydrochloride Extended -release Tablets USP, 100 mg, 200 mg and 300 mg.
AstraZeneca and Eli Lilly deepening their collaboration in cancer immunotherapy by testing new drug combinations for treating solid tumours.
There is good news for people suffering from hair loss. In experiments with mouse and human hair follicles, researchers have found that certain existing drugs promote rapid and robust hair growth when directly applied to the skin.
Never before in the history of polio have so few children contracted the virus, but the international community cannot rest until the number of cases is zero, the UN Children's Fund (UNICEF) said on the eve of World Polio Day.
The American Association of Physicians of Indian Origin (AAPI) will hold its 10th Global Health Summit from Jan 1 to 3 in New Delhi with a focus on women's health and non-communicable diseases in India.
Over 1,000 women were screened for breast cancer on Friday on the first day of a free screening and awareness camp held here.
[adsense:336x280:8701650588]
In Vitro Fertilisation (IVF) is emerging as an easy way of having twins and triplets for working parents and Indian couples desirous of having twins were deliberately opting for IVF treatment, doctors said on Friday.
Bacon, ham and sausages have the same cancer risk as cigarettes, according to a report by the World Health Organisation (WHO), set to be published on Monday, a media report said.
The latest edition of Grand Challenges India (GCI), which aims to boost innovation by Indian researchers through technological advancements, will target nutritional interventions in child health, an official said on Friday.
The anti-malarial compound Artemisinin, the discovery of which won Tu Youyou China's first Nobel Prize for Physiology or Medicine this year, has not resulted in big profits for Chinese pharmaceutical companies.